The company aims to test 10,000 personalized mRNA therapies, including cancer vaccines, between September 2023 to the end of the decade.
You are here: Home / BioNTech says it will start cancer vaccine trials in the UK from September
Market News and Views
The company aims to test 10,000 personalized mRNA therapies, including cancer vaccines, between September 2023 to the end of the decade.